GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

Risk Stratification and Screening for Early Onset Colorectal Cancer

Fight Colorectal Cancer

J. Demb, F. May, A. Zauber, I. Lansdorp-Vogelaar, A. Shaukat, J. Perea Garcia, H. Hampel

Organ Preservation in Rectal Cancer: Neoadjuvant Short-Course RT vs.…

Memorial Sloan Kettering Cancer Center

P. Romesser

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

Using ctDNA to Guide Adjuvant Therapy in GI Malignancies

University of Miami Sylvester Comprehensive Cancer Center

P. Hosein

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Tri…

2024 ASCO® Annual Meeting Insights Hub

J. Tie

Personalized MRD Assessment and Treatment Decision-Making in CRC: Up…

UChicago Medicine

B. Polite

ESMO 2024 Summary: Liquid Biopsies in GI Cancers - Learnings From Co…

2024 ESMO Annual Meeting Insights Hub

N. Starling

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

Anal Cancer Staging and Treatment Options

GRACE

P. Romesser

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito